NCT03171740View on ClinicalTrials.gov

Premedication With Intranasal Dexmedetomidine or Midazolam for Prevention of Emergence Agitation in Children

PHASE3CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

June 1, 2017

Primary Completion Date

December 1, 2017

Study Completion Date

January 15, 2018

Conditions

Emergence Delirium

Interventions

DRUG

Dexmedetomidine

Intranasal dexmedetomidine, 1mcg/kg (it is a 100mcg/ml solution)

DRUG

Midazolam oral solution

Oral midazolam, 0.5mg/kg (its a 2mg/ml solution)

DRUG

Oral saline

Oral saline, 0.25ml/kg

DRUG

Nasal saline

Nasal saline 0.01ml/kg

Trial Locations (1)

7000000

University Hospital of Brasilia University, Brasília

All Listed Sponsors

lead

Brasilia University Hospital

OTHER

NCT03171740 - Premedication With Intranasal Dexmedetomidine or Midazolam for Prevention of Emergence Agitation in Children | Biotech Hunter | Biotech Hunter